| Application | Recommended Dilution |
|---|---|
| FC | 1:50-1:200 |
BGLAP, commonly known as osteocalcin, serves as a critical marker in bone biology research, functioning as the most abundant non-collagenous protein in bone matrix. Secreted exclusively by osteoblasts, this vitamin K-dependent protein plays essential roles in bone mineralization and calcium homeostasis. Beyond its skeletal functions, osteocalcin has emerged as a fascinating research target due to its endocrine activities, including regulation of glucose metabolism and energy expenditure, making it relevant to studies spanning osteoporosis, metabolic disorders, and bone-related diseases.
This recombinant monoclonal antibody, clone 16A8, offers researchers the reproducibility and consistency that recombinant technology provides. Unlike traditional hybridoma-derived antibodies, this sequence-defined reagent ensures identical performance across lots, eliminating batch-to-batch variability that can compromise longitudinal studies or multi-site collaborations. The human IgG1 isotype format and affinity-chromatography purification deliver a highly specific reagent suitable for demanding experimental workflows.
Validated for ELISA and flow cytometry applications, this antibody demonstrates reliable detection of human BGLAP. Flow cytometry validation using U87 cells confirms specific intracellular staining when cells are fixed and permeabilized, with recommended dilutions ranging from 1:50 to 1:200. The validation data shows clear separation between antibody-stained and isotype control populations, indicating robust signal-to-noise performance for quantitative cellular analysis.
Whether investigating osteoblast differentiation, exploring osteocalcin's metabolic signaling functions, or developing diagnostic assays for bone turnover markers, this antibody provides a dependable tool for advancing your research into bone biology and its broader physiological connections.
Email: support@cusabio.com
Distributors Worldwide